dihydroergotamine has been researched along with dalteparin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humphrey, PW; Keller, MP; Kikta, MJ; Silver, D | 1 |
| Kivioja, A; Lindevall, K; Myllynen, P; Perhoniemi, V; Vuorinen, J | 1 |
1 trial(s) available for dihydroergotamine and dalteparin
| Article | Year |
|---|---|
The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Topics: Adult; Aged; Anticoagulants; Dihydroergotamine; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Enoxaparin; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Hip; Humans; Injections, Subcutaneous; Knee; Male; Middle Aged; Phlebography; Postoperative Complications; Safety; Thrombophlebitis; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasoconstrictor Agents | 1996 |
1 other study(ies) available for dihydroergotamine and dalteparin
| Article | Year |
|---|---|
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia | 1993 |